Showing results (141-150 of 250) with videos related to
Sort By:
Pageof 25
Addiction Biology|January 3, 2021
5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokersCaroline A Arout, Ziva D Cooper, Stephanie Collins Reed, et al.Biorxiv : the Preprint Server for Biology|February 17, 2023
Neural correlates of drinking reduction during cognitive behavioral therapy for alcohol use disorderNasir H Naqvi, A Benjamin Srivastava, Juan Sanchez-Peña, et al.Drug and Alcohol Dependence|December 21, 2004
Utility of lead-in period in cocaine dependence pharmacotherapy trialsAdam Bisaga, Efrat Aharonovich, Fatima Garawi, et al.European Addiction Research|July 3, 2020
Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric ComorbidityMaría C Vélez-Pastrana, Rafael A González, Alexandra Ramos-Fernández, et al.The American Journal of Drug and Alcohol Abuse|January 11, 2023
Sublingual dexmedetomidine (BXCL501) reduces opioid withdrawal symptoms: findings from a multi-site, phase 1b/2, randomized, double-blind, placebo-controlled trialJermaine D Jones, Lavanya Rajachandran, Frank Yocca, et al.The Journal of Clinical Psychiatry|November 16, 2013
Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment responseEdward V Nunes, Lirio S Covey, Gregory Brigham, et al.Advances in Medical Education and Practice|July 9, 2020
Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) CurriculumJeremy D Kidd, Jennifer L Smith, Mei-Chen Hu, et al.Frontiers in Public Health|June 4, 2026
Structural stressors, neurocognition in reward-related decision making and substance use risk in Puerto Rican early adolescents at two sites: study designTamara J Sussman, Ligia M Chavez, Melanie Wall, et al.Journal of Substance Abuse Treatment|February 25, 2014
A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.Addiction Biology|April 17, 2018
Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokersMargaret Haney, Ziva D Cooper, Gillinder Bedi, et al.Pageof 25